Marianne Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP, FAAN, is a board-certified acute care nurse practitioner. She is an associate professor at Yale School of Nursing, coordinating the Oncology Nurse Practitioner concentration. Her clinical practice is at the Yale Comprehensive Cancer Center, Medical Oncology Division with specialization in immunotherapy, targeted therapies, and management of associated toxicities.
Dr. Davies is a member of the Advanced Practitioner Society for Hematology and Oncology, Oncology Nursing Society, International Association for the Study of Lung Cancer, International Thoracic Oncology Nursing Forum, Society for Immunotherapy of Cancer (SITC), Association of Community Care Centers’ Institute for Clinical Immuno-Oncology, National Comprehensive Cancer Network, and AIM with Immunotherapy Foundation. She serves on the Immunotherapy Guideline Development Board of the SITC, National Comprehensive Cancer Network, and American Society of Clinical Oncology. She has published and presented extensively on the topics of lung cancer, immunotherapy, targeted therapy, and symptom management. Dr. Davies was also recently inducted as a fellow in the American Academy of Nursing in 2020.
She is a graduate of the Yale University School of Nursing. Dr. Davies received her Master of Science in Nursing of Oncology Clinical Nurse Specialist and Post-Master's Certificate of Acute Care Nurse Practitioner. She then received her Doctor of Nursing Practice from MGH Institute of Health Professions.